Many studies have found that inhibition of Notch1 expression in many tumors, such as breast, pancreatic, and colon cancers, increases the sensitivity of tumor cells to chemotherapeutic drugs. This evidence concerns the gene NOTCH1 and malignant colon neoplasm.